nct_id: 'UW-23-187'
age: Adults
cancer_center_accrual_goal_upper: 0
data_table4: 'Interventional'
drug_list:
  drug:
    - drug_name: 'Sacituzumab Govitecan'
long_title: 'A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated with Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1 (Ascent-03)'
management_group_list:
  management_group:
  - is_primary: Y
    management_group_name: HKUMed
oncology_group_list:
  oncology_group:
  - group_name: Group 1
    is_primary: N
phase: '3'
principal_investigator: 'Dr Wendy CHAN'
program_area_list:
  program_area:
  - is_primary: Y
    program_area_name: Program 1
protocol_id: 
protocol_no: ''
protocol_target_accrual: 0
protocol_type: ""
prior_treatment_requirements: 
  - 'Triple negative: ER(-), PR (-), HER2(-)'
  - 'Inoperable, locally metastatic TNBC'
  - 'Previously untreated PD-L1 Negative. OR PD-L1 Positive in patients previously treated with an anti-PD-L1 agent in the curative setting.'
  - '≥ 6 months since treatment in curative setting.'
short_title: 'Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Triple-Negative Breast Cancer'
site_list:
 site: []
sponsor_list:
 sponsor: []
staff_list:
 protocol_staff: []
status: open to accrual
summary: ''
treatment_list:
  step:
  - arm:
    - arm_code: Arm A
      arm_internal_id: 1111
      arm_description: 'Treatment with Sacituzumab Govitecan'
      arm_suspended: N  
    - arm_code: Arm B
      arm_internal_id: 2222
      arm_description: 'Control'
      arm_suspended: N 
    step_code: '1'
    step_type: 'Registration'
    step_internal_id: 1111
    match:
        - and:
          - clinical:              
              oncotree_primary_diagnosis: 'Invasive Breast Carcinoma'
              disease_status:
                - 'Locally Advanced'
                - 'Metastatic'
              her2_status: 'Negative'
              er_status: 'Negative'
              pr_status: 'Negative'               
              